Neurointerventional Devices Market Scope And Analysis

  • Report Code : TIPRE00005548
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neurointerventional Devices Market Scope and Analysis Report by 2031

Buy Now

Neurointerventional Devices Market Report Neurointerventional Devices Market Size and Share Neurointerventional Devices Market Scope and Analysis

Neurointerventional Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3.00 billion
Market Size by 2031 US$ 5.95 billion
Global CAGR (2023 - 2031) 8.9%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Neurovascular Thrombectomy Devices
  • Neurovascular Stents
  • Embolic Protection Devices
  • Intrasaccular Devices
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolics
  • Balloons
  • Stent Retrievers
By Technique
  • Neurothrombectomy
  • Stenting
  • Coiling Procedure
  • Cerebral Angiography
  • Flow Disruption
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Boston Scientific Corporation
  • Stryker
  • iVascular S L U
  • Terumo Corporation
  • Merit Medical Systems
  • Penumbra Inc
  • Rapid Medical
  • MicroPort Scientific Corporation
  • InspireMD Inc

    • Neurointerventional Devices Market News and Recent Developments

    The Neurointerventional Devices Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for neurointerventional devices and strategies:

    • Avicenna.AI received FDA 510(k) clearance for Cina-iPE and Cina-ASPECTS. Cina-iPE enables incidental detection of pulmonary embolism (PE), and Cina-ASPECTS provides automatic assessment of stroke severity. (Source: Bryn Mawr Communications II LLC, Press Release, 2024)
    • Cerenovus, Inc., part of Johnson & Johnson MedTech, Inc., launched Cereglide 71 aspiration catheter in Europe. The Cereglide 71 provides direct aspiration of blood clots and for the delivery of compatible stent retrievers—including the company’s Embotrap III revascularization device and the Cerenovus Nimbus geometric clot extractor—into the neurovasculature.  (Source: Bryn Mawr Communications II LLC, Press Release, 2024)

    Neurointerventional Devices Market Report Coverage and Deliverables

    The “Neurointerventional Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles